Sigma Company Limited Summary

In the recent decision of Sigma Company Limited, the Fair Work Commission (FWC) addressed a dispute concerning the validity of an enterprise agreement. Sigma, an employer, contested the agreement's validity on the basis that it did not comply with certain statutory requirements. The matter was brought before the FWC, which was tasked with determining the validity of the agreement.

The central legal issue before the FWC was whether the enterprise agreement met the prerequisites outlined under section 185 of the Fair Work Act 2009. This section stipulates specific conditions that must be satisfied for an enterprise agreement to be valid, including that it must be in writing, cover a specified enterprise or group of enterprises, and meet the requirements for certification. Sigma argued that the agreement did not adequately meet these conditions, particularly in relation to the definition of the enterprise covered by the agreement.

The FWC examined the agreement in detail, considering the evidence presented by both parties. The Commission found that the agreement was indeed in writing and covered the appropriate enterprise. However, it identified several deficiencies in the agreement's certification process. The FWC concluded that the agreement did not meet the statutory requirements, leading to its invalidation. Consequently, the Commission ruled that the enterprise agreement was not valid, and as such, did not bind the parties to its terms.

The FWC's decision highlights the importance of strict compliance with statutory requirements for enterprise agreements. Employers and employees must ensure that agreements are properly certified and meet all legal prerequisites to avoid similar outcomes. This ruling serves as a reminder of the need for meticulous attention to detail in the drafting and certification of enterprise agreements.

Sigma Company Limited

CORRECTION TO DECISION

CaseChat Overview and Summary

Orders of the court

Background to the litigation

Evidence Before The Court

Reasons for decision

Legal Principle Established

Pharmaceutical industry
DEPUTY PRESIDENT GOSTENCNIK	MELBOURNE, 4 DECEMBER 2014